Back to Search Start Over

Poster: AML-065: Measurable Residual Disease Status and FLT3 Inhibitor Therapy in Patients with FLT3-ITD-Mutated AML Following Allogeneic Hematopoietic Cell Transplantation

Authors :
Emily C. Liang
Connie Chen
Rong Lu
Gabriel N. Mannis
Lori Muffly
Source :
Clinical Lymphoma Myeloma and Leukemia. 21:S210
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
21522650
Volume :
21
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........f25b67da29a8ee4afbfd6c36f6d28256
Full Text :
https://doi.org/10.1016/s2152-2650(21)01313-6
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details